Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease esophageal cancer
Symptom C0011168|dysphagia
Sentences 26
PubMedID- 24906258 esophageal cancers rather present with dysphagia, odynophagia or systemic symptoms.
PubMedID- 24794023 A 73-year-old man with a chief complaint of dysphagia was diagnosed with thoracic esophageal cancer at a local hospital.
PubMedID- 20538080 Conclusion: jejunostomy feeding catheter provided nutritional access to oesophageal cancer patients with complete dysphagia using a locally prepared formula.
PubMedID- 21991527 Brachytherapy has been found to palliate dysphagia effectively in patients with advanced esophageal cancer, providing a sustained improvement in dysphagia symptoms and quality of life over time.
PubMedID- 21742654 Objective: to retrospectively assess the efficacy and safety of palliative chemoradiotherapy in stage ivb esophageal cancer patients with dysphagia due to the primary lesion.
PubMedID- 23370813 Radiological image-guided placement of covered niti-s stent for palliation of dysphagia in patients with cervical esophageal cancer.
PubMedID- 26464685 Objective: although the placement of esophageal self-expandable stents (ses) can effectively relieve dysphagia after radiotherapy in patients with esophageal cancer (ec), it may induce severe esophageal complications.
PubMedID- 25731398 Case 3: a 66-year-old man presented with dysphagia due to esophageal cancer at the lower thoracic esophagus.
PubMedID- 20567597 dysphagia, the main symptom of esophageal cancer, is very characteristic of this disease, and the availability of at least 10 ugi endoscopy clinics in the region, three providing free-of-charge endoscopy services to the gcs subjects, has made it possible to have accurate histologic diagnoses for almost all ugi cancers.
PubMedID- 24841543 We compared the self-expanding irradiation stent with a conventional self-expandable covered stent in patients with malignant dysphagia due to recurrent esophageal cancer.
PubMedID- 25789035 In the present study, a retrospective analysis of 24 patients exhibiting esophageal cancer with dysphagia was performed in a single institute (university of tokyo hospital).
PubMedID- 25992812 Conclusions: small-diameter and large-diameter esophageal sems provided similar palliation of dysphagia due to esophageal cancer.
PubMedID- 22115214 Results: most stents were placed for palliation of dysphagia due to advanced esophageal cancer (90 of 133; 68%) or extrinsic compression from lung cancer (13 of 133; 9.8%).
PubMedID- 24390360 Conclusion: the device is safe and effective for the treatment of patients with dysphagia due to esophageal cancer.
PubMedID- 20859687 Background: expandable esophageal stents are widely used for the palliation of dysphagia in patients with esophageal cancer and are also beginning to be used in patients with benign esophageal diseases such as refractory strictures and fistulas.
PubMedID- 20835926 Study aim: to compare the duration of relief of dysphagia in patients with inoperable esophageal cancer treated with esophageal stenting alone or a combination of esophageal stenting and external beam radiotherapy (ebrt), and to assess overall survival, treatment-related complications, and quality of life (qol) in the two groups.
PubMedID- 19788439 Self-expandable metal stents (sems) have been mostly reserved for palliation of dysphagia because of advanced esophageal cancer.
PubMedID- 20890057 Esophageal stents for the treatment of malignant dysphagia in patients with esophageal cancer.
PubMedID- 24674161 Purpose: palliative radiotherapy has traditionally been used as a noninvasive means of palliating dysphagia in patients with incurable esophageal cancer.
PubMedID- 24550996 A variety of approaches are available for the palliation of malignant dysphagia due to oesophageal cancer.
PubMedID- 22849981 The problem pattern did not differ between disease groups apart from dysphagia in oesophageal cancer.
PubMedID- 25731272 Two years later, the patient had dysphagia and was diagnosed with esophageal cancer based on upper gastrointestinal endoscopy.
PubMedID- 26542798 Hence, esophageal stenting is considered an option for esophageal cancer patients with severe dysphagia combined with a short life expectancy or recurrent tumor growth after cancer treatment .
PubMedID- 26045491 We report tracheal-bronchial migration of a covered esophageal self-expanding metal stent used to relieve dysphagia in a patient with advanced esophageal cancer.
PubMedID- 23964331 On the basis of these data, covered and new double-layered covered semss are preferred for the palliation of malignant dysphagia due to unresectable esophageal cancer.
PubMedID- 26016143 To control dysphagia 202 patients with a verified esophageal cancer of stage ct1-4n0-2m0-1 underwent intraluminal brachytherapy with neoadjuvant chemoradiotherapy in the process of combined radiation/chemoradiation therapy and palliative treatment.

Page: 1